New LC-MS/MS method provides an alternative to the current LC-HRMS method

Ranitidine (Zantac) recall brings into question the analytical methods used to detect NDMA

Detection of NDMA in ranitidine drugs (Zantac) led to a recent recall. While the carcinogenic effects in humans are not conclusive, NDMA is considered a probable human carcinogen

Company that detected impurities in ranitidine drugs says FDA testing methodology is insufficient, while FDA counters that the company’s testing method was inaccurate

The results of a recent study raise questions about whether current surface detection methods allow people living inside a former meth house to understand the extent of contamination that's present,

Breakthrough study fills a 'missing gap,' Baylor University researcher says

Despite significant investments into cancer research over the last decades, 1.7 million new cancer cases were estimated in the U.S. in 2017